Followers | 230 |
Posts | 15196 |
Boards Moderated | 0 |
Alias Born | 03/30/2005 |
Wednesday, September 10, 2014 9:47:48 AM
may 27, 2014: after several years of being dormant, an update comes out on the OTC talking about a secured LC in 2011 that was secured with the issuance of preferred shares. It's this pref shareholder (control block) who announced to the world that CSCE is going to r/m with a new company
june 17, 2014: a super 8k comes out with 13 filings bunched into one to bring CSCE's status from caveat emptor to current so they can do a r/m with a private company
At random times from June to August, IR updates investors that the OTC marketplace wants those filings separated from each other and be xbrl compliant. Per IR, it would have cost $50 - $75k to turn it around in 30 days. To save money, IR farms out the super 8k and has it done in 60-90 days. If we were looking at a map in the mall to find our location, it would say "you are here" - this is exactly where we are.
It's assumed all the filings are done. About 2 weeks ago IR say 8 of the 13 filings were done (60%). Since CSCE has been dormant, the last 5 filings are done in the blink of an eye. Now we all are waiting on the edge of our seats waiting for an update
On Friday Sept 5th IR closes the deal on the preferred shares, meaning IR is no longer involved with CSCE as of Friday (logic says that IR was the pref shareholder). The only thing they know is the new preferred holder is from the mining industry, so IR assumes the merger will be with a mining company. Anyone who has followed IR's track record knows they are anything but reliable.
What we do know is they (IR) are no longer are involved here, meaning there is a new owner. Next steps? Usually a SOS update followed by the filings and an attorney letter bringing CSCE's status to current.
the above is all IMHO (consider this my safe harbor statement)
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM